|
|
|
|
|
A baker’s dozen of biopharma CEOs answer a call to prioritize and describe challenges they expect to face in the coming year. |
|
|
|
Think real-world data’s only application is clinical trials? Think again. Savvy early-stage biotechs are leveraging RWD in their formative stages, long before entering the clinic, to drive critical efficiencies in drug discovery and development. |
|
|
|
We catch up with Dr. Konstantin Konstantinov, CTO at Ring Therapeutics, and Ryan Crisman, Ph.D., cofounder and CTO at Umoja Biopharma, to get their thoughts on the future of new anellovirus vectors and existing lentiviral vector technology for in vivo gene delivery, respectively. |
|
|
|
|
|
|
|
|
|
Inside you will find more on: - Funding Forecast
- Supply Chain Predictions
- Executive Outlook
- Leadership For Tomorrow
View the digital edition. |
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
Connect With Life Science Leader: |
|
|
|